Non-Small Cell Lung Cancer with EGFR Mutations | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

Featuring perspectives from Dr Joshua K Sabari and Dr Helena Yu, including the following topics:

• Introduction: Checkpoint Inhibitors and Lung Cancer with an EGFR Mutation (0:00)
• Current Management of Metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations — Dr Sabari (5:39)
• Novel Therapeutic Approaches for NSCLC Harboring EGFR Mutations — Dr Yu (28:21)

CME information and select publications